chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small scabs in the area; Has not received the 2nd vaccine; Hives goes from left side of back, bra and waist; Left arm and hand got tingly; Arm got sore; A spontaneous report was received from a 75-year-old elderly female patient who received Modern's COVID-19 vaccine (mRNA-1273) and experienced small scabs in the area(vaccination site scab), hives goes from left side of back, bra and waist(urticaria), arm got sore(pain in extremity), left hand and arm got tingly(paresthesia) and had not received the 2nd vaccine(product dose omission issue).  The patient's medical history included allergic to aspirin, penicillin, cats and mold. Concomitant product use was not provided by the reporter.  On 09 Feb 2021, prior to the onset of the events, the patient received her first of the two planned vaccine doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 09 Feb 2021, after the first dose of vaccine, the patient's arm got sore for 24 hours.  On 10 Feb 2021, the left arm and hand got tingly and reportedly this went away.   On 11 Feb 2021, she had hives that went from left side of back, bra and waist and reportedly went away. She had not received the 2nd vaccine dose.   On 22 mar 2021, it was reported that she still had small scabs in the area. No treatment medication was reported.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, arm got sore was unknown, small scabs in the area was not resolved, left arm and hand got tingly, hives goes from left side of back, bra and waist was resolved on an unspecified date in 2021, outcome of the event not received the 2nd vaccine was considered to be resolved on 09 Mar 2021.; Reporter's Comments: This report refers to a case of product dose omission issue for mRNA-1273, lot # Unknown, with no associated AEs. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient was admitted to hospital with fever, rash.  Tested positive for strep.  After several days of hospitialization and screening for other diseases, the diagnosis of juvenille rheumatoid arthritis was made and he was started on steroids and anti-inflamatory. Follow up on 08/20/2003: "Mom states Heb B vaccine was not Heptavax but "the other Merk Hep B.  She made an error on her web report." The discharge summary received on 1/12/04 confirms diagnosis of juvenile rheumatoid arthritis. Also add asthenia, myalgia, headache, and blisters in mouth.
Vomiting, chills, muscle soreness and weakness, mild/dull headache.
Redness and erythema left anterior medial thigh, [(+) warmth, (-) drainage] area marlied extending down the thigh in 24 hours given rocephin augmentin.
This spontaneous report as received from a pharmacist refers to a male patient of currently 60 years. Patient's medical history and drug reactions were not provided. On an unknown date the patient was vaccinated with MMR II (dose, duration and lot were not reported) for traveling out of country". Other suspect therapies included HEPATITIS A virus vaccine (manufacturer unknown), MENINGOCOCCAL vaccine (manufacturer unknown), POLIOVIRUS vaccine inactivated (manufacturer unknown) and YELLOW FEVER virus vaccine (manufacturer unknown).  On an unknown date, the patient experienced developed joint pain. The patient did not see medical attention. The outcome of developed joint pain was reported as recovering/resolving. Additional information has been requested.
hospitilization, too long prior to admission for symptom onset. Supportive care only in Coronary Care Unit
Swelling on the left hand (fingers) - a ring couldn't be taken off. The injection site was red and very itchy - that lasted for about three days. There was a lot of drowsiness; fatigue; upset stomach - lasted about a week.  Went to Primary care doctor; he said it was a side affect. He told us to keep an eye on it. The swelling lasted three or four days.
- New, random, and episodic flushing in face and neck (never experienced before) that can last for hours - Unprovoked variability in resting heart rate and blood pressure - Chest discomfort - Dyspnea - Brain fog
Initial information and follow up has been received from a health professional concerning a 21 year old female with allergic rhinitis, gastroesophageal reflux disease and drug reactions/allergy to STRATTRA who on 29-FEB-2008 was vaccinated with her first dose of GARDASIL (lot# not reported). Concomitant therapy included a topical antifungal drug (unspecified) and hormonal contraceptives (unspecified). In the beginning of April 2008, the patient experienced hives. The hives appeared after certain activities such as after taking a shower, and then disappeared. However, the hives appeared again a few days later. The patient was seen by the nurse practitioner and was recovering. The patient was also recently tested for tuberculosis and the PPD test was positive, but the chest x-ray was negative. The patient had recent travel out of the country and recent foot fungus.
Felt mild itchiness at various parts of my body, starting a few hours after the shot was given. I'm not positive if the itchy feelings began within the first 4 hours after the shot, but I think so. I took an antihistamine before bed that night. The next day I occasionally felt very minor tingling, which I believe was the itchiness diminishing. By the third day the itchiness/tingling was gone. I never developed a rash, hives, or swelling. I spoke with my primary care physician during an unrelated annual physical exam that took place a couple days after the vaccination, and he said it's possible it was a very mild allergic reaction, but in his determination it was nothing to be concerned about or to prevent me from getting the second dose of the Pfizer vaccine 21 days later.
vaccine was administered on 10/05/2021 it had expired on 10/01/2021
A week after the 2nd vaccine, she was extremely tired and fatigued. A couple weeks afterwards, she was starting to have chest pain and/or sensations. She started to notice that she was having intermittent issues with catching her breath and feeling dizzy. We spoke with her physician and was at a loss for words and thought that everything should have been fine since her last check up. She also had dementia that became more problematic for her health. At that time the doctor wanted to place her in assisted living, her niece noticed that she was starting to have many more falls that persisted and caused more issues with her health. Within a month she complained about intermittent chest pain, by July developed pneumonia. Upon chest x-rays they did see some clouding and was sent back to her nursing home. EKG nothing was alarming, she was having dizziness and hit her head after falling. Doctors did not know if she had congestive heart failure or pneumonia only. She had a second fall shortly afterwards, the cardiologist stated that she has significantly worsened in her health status. Soon after being placed on hospice, she passed away. It is believed that she had numerous blood clots that came after the vaccine and had caused the death.
about 2 weeks after the 2nd dose became lethargic, no appetite, sleepy, swelling in feet, painful to walk, hands occasionally also hurt, nausea on/off, diareaha
Patient with persistent and chronic fatigue. She can no longer perform activities that she once did. She takes an hour nap in the morning and 2 hour nap in the afternoon. She has no energy. She no longer goes for walks.
This case was reported by a consumer via other manufacturer and described the occurrence of increased blood pressure in a female patient who received Shingrix for prophylaxis. Co-suspect products included Aubagio for drug use for unknown indication. On an unknown date, the patient received Shingrix. In February 2018, the patient started Aubagio at an unknown dose and frequency. On an unknown date, less than a year after receiving Shingrix, the patient experienced increased blood pressure. The action taken with Aubagio was unknown (Dechallenge was unknown). Rechallenge with Aubagio was unknown. On an unknown date, the outcome of the increased blood pressure was unknown. It was unknown if the reporter considered the increased blood pressure to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. On 8th June 2018, the patient began experiencing forgetting that she should not have live vaccinations while taking Aubagio, and took 1 injection of the shingles vaccine Shingrix. Since starting February 2018, the Aubagio in patient began experiening, her blood pressure being elevated.
Mom called to report that she took pt to ER the day after receiving injections because of persisting fever and irritability. No swelling, no redness at sites. Today child is still irritable but not febrile. Advised to give Motrin and bring child to clinic if still irritable.
alert, emesis overfed, rt eyelids upper & lower swollen, scleral inj, profuse tearing from rt eye, lt nasal area swollen nasal stuffiness & nasal discharge, watery;
Patient has experienced persistent change in sense of taste and smell since the day after 1st dose of COVID vaccine. Coffee is the only thing that tastes different, chemically. Anything tomato based will smell like enchiladas. Perfume smells different and she cannot stand the smell now. Shampoo smells different than usual. To note, patient was infected with COVID-19 in November 2020 and experienced loss of taste and smell senses, which resolved within a few weeks and well before 1st vaccine dose.
3 days after FLUMIST developed bilateral ear pain & serous drainage. Seen 5 days after FLUMIST & has bilateral bullous myringitis with draining bullae.
Heavy vaginal bleeding for more than 3 weeks, since receiving the booster shot.  I was not due for a period, I am on oral contraceptive, I have been bleeding for more than 3 weeks and the bleeding still persists. metrorrhagia polymenorrhea menorrhagia
Wheezing; Dry cough at rest or while talking; This is a spontaneous report from a contactable healthcare professional (patient). A non-pregnant 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), intramuscular in left arm, in Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications included Cichorium intybus extract/ Embelia ribes powder/ Glycyrrhiza glabra extract/ Operculina turpethum extract/ Senna occidentalis extract/ Solanum nigrum extract/ Terminalia chebula extract/ Zingiber officinale powder (HERBOLAX), levothyroxine sodium (SYNTHROID), sertraline hydrochloride (ZOLOFT), and ezetimibe (ZETIA). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a public health clinic. On 13Jan2021 at 07:00 PM (19:00), the patient experienced wheezing within 2 to 3 days and dry cough at rest or while talking. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
Awoke with severe neck with all over headache/ felt like head is vice; Awoke with severe neck with all over headache; I had joint and muscle pain for 4 days; I had joint and muscle pain for 4 days; BOOSTER; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 24Sep2021 10:00 (Lot number: 30130BA) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose:1, Date:27Jan2021, Time: 11 AM, Anatomical site of injection: right arm, Batch/lot number: EL3247), administration date: 27Jan2021, when the patient was 75 years old, for Covid-19 immunization; Bnt162b2 (Dose:2, Date:17Feb2021, Time: 11 AM, Anatomical site of injection: right arm, Batch/lot number: EL9263), administration date: 17Feb2021, when the patient was 75 years old, for Covid-19 immunization, reaction(s): "i had joint and muscle pain", "i had joint and muscle pain". The following information was reported: IMMUNISATION (non-serious) with onset 24Sep2021 10:00, outcome "unknown", described as "BOOSTER"; ARTHRALGIA (non-serious), MYALGIA (non-serious) all with onset 24Sep2021 23:00, outcome "recovered" (2021) and all described as "I had joint and muscle pain for 4 days"; HEADACHE (non-serious) with onset 26Sep2021, outcome "recovered" (2021), described as "Awoke with severe neck with all over headache/ felt like head is vice"; NECK PAIN (non-serious) with onset 26Sep2021, outcome "recovered" (2021), described as "Awoke with severe neck with all over headache". Therapeutic measures were taken as a result of arthralgia, myalgia, headache, neck pain.  Additional information: Booster dose due to high risk of frequent institutional or occupational exposure to coronavirus (and at risk of serious covid -19 complication). Specific relevant test for thromboembolic events with thrombocytopenia: None. Booster: Started with muscle with joint aches about 12 hours after shot. Took Tylenol. On 25Sep- moderate- severe joint with muscle aches all day- took Tylenol. On 26Sep- awoke with severe neck with all over headache felt like head is vice, took Tylenol plus Ikg. On 27Sep- still painful headache, joint pain. Joint pain a little better, took advil. On 28Sep - 30Sep: pain lessened each day ,took Advil until the 29th. Patient didn't receive any other vaccine within 4 weeks prior to COVID vaccine. Patient received any other medication within 2 weeks of vaccination. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination patient was not tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender.  The patient's medical history and drug reactions / allergies were not reported. On 28-AUG-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX lot # N012614, expiration date: 16-MAR-2018, for prophylaxis. Concomitant therapies included sterile diluent (STERILE DILUENT) lot # N015478, expiration date: 28-SEP-2019. No adverse events were reported. Administered vaccines experienced a temperature excursion of 17.4F for a time frame of 1 hour and 48 minutes. There was no previous temperature excursion. Data logger was reported as "Yes". This is one of two cases received from the same reporter.; Sender's Comments: US-009507513-1709USA014939:
Received vaccines on 3-16-09.  The evening of vaccine she got a fever + slept poorly.  In the morning after the vaccine was disoriented + needed help watching her child due to "spacey" feeling.  "I couldn't feel the ground I was walking on".  Even her legs felt weak and spacey.  She pinched herself to make sure she had feeling.  Feeling was diminished but present.  Pt also had diarrhea.  Spacey feeling lasted 3 days- Fever lasted 4 days.  Today (11 days later) she feels weak, slightly dizzy + fatigued, but getting better able to eat + drink today with difficulty.
Severe chills occurred approximately 6 hours after receiving vaccine. High fever (101) also occurred within the same timeframe. Approximately 8 hours after receiving the shot, severe and sudden nausea occurred, causing the patient to violently vomit in the middle of the night.   Patient awoke the next morning, about 15 hours after receiving the shot, with body aches, chills, minor low grade fever, headache, and dehydration. After 24 hours, the patient felt fine.
down for 24 hours; Diarrhea; Nausea; Fever; got really sick with chills; got really sick with chills/got really sick; body aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (down for 24 hours), DIARRHOEA (Diarrhea), ILLNESS (got really sick with chills/got really sick), PAIN (body aches) and NAUSEA (Nausea) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (down for 24 hours), DIARRHOEA (Diarrhea), ILLNESS (got really sick with chills/got really sick), PAIN (body aches), NAUSEA (Nausea), PYREXIA (Fever) and CHILLS (got really sick with chills). At the time of the report, MALAISE (down for 24 hours), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) outcome was unknown and ILLNESS (got really sick with chills/got really sick), PAIN (body aches), PYREXIA (Fever) and CHILLS (got really sick with chills) had resolved.            No concomitant medications were reported. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jan-2022: Reporter details, Patient details, Suspect product details, Events and Events outcome was updated.
pt recvd vax; febrile sz, 4 min; seen in er; tx w/ ibuprophen;
NECK PAIN; FELT LIKE SOMETHING WAS IN THERE WHERE GOT SHOT IN RIGHT ARM; PAIN IN ARM WHERE GOT SHOT; RIGHT ARM FELT STIFF AND TIGHT; WHEN PUT HAND IN AIR HAS TO GUIDE IT WITH OTHER ARM; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 202A21A expiry: 21-SEP-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient experienced right arm felt stiff and tight. On 07-APR-2021, the patient experienced when put hand in air has to guide it with other arm. On 07-APR-2021, the patient experienced felt like something was in there where got shot in right arm. On 07-APR-2021, the patient experienced pain in arm where got shot. On an unspecified date, the patient experienced neck pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from when put hand in air has to guide it with other arm, pain in arm where got shot, felt like something was in there where got shot in right arm, and right arm felt stiff and tight, and the outcome of neck pain was not reported. This report was non-serious.
Left side jaw pain and red raised itchy rash at injection site and down arm to elbow.
Pt had headache that began 12 hours after her Flu shot. The headache lasted for 4 weeks.
Deep vein thrombosis and cerebrovascular accident/left leg DVT; cerebrovascular accident; This spontaneous case was reported by a nurse and describes the occurrence of DEEP VEIN THROMBOSIS (Deep vein thrombosis and cerebrovascular accident/left leg DVT) and CEREBROVASCULAR ACCIDENT (cerebrovascular accident) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus, Hypertension and Hypersensitivity (hypersensitivity lung disease).   On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Sep-2021, the patient experienced DEEP VEIN THROMBOSIS (Deep vein thrombosis and cerebrovascular accident/left leg DVT) (seriousness criteria hospitalization and medically significant) and CEREBROVASCULAR ACCIDENT (cerebrovascular accident) (seriousness criteria hospitalization and medically significant). At the time of the report, DEEP VEIN THROMBOSIS (Deep vein thrombosis and cerebrovascular accident/left leg DVT) and CEREBROVASCULAR ACCIDENT (cerebrovascular accident) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Currently on anticoagulant therapy.  Company comment: This case concerns a 78-year-old, female patient with previous relevant medical history of Type 2 diabetes mellitus and Hypertension, who experienced the unexpected serious AESI events of Deep vein thrombosis and cerebrovascular accident. The events occurred 3 days after the second dose of mRNA-1273 Moderna vaccine. The rechallenge was not applicable, as the outcome of the events was unknown.  The medical history of Type 2 diabetes mellitus and Hypertension could be confounders.  The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.; Sender's Comments: This case concerns a 78-year-old, female patient with previous relevant medical history of Type 2 diabetes mellitus and Hypertension, who experienced the unexpected serious AESI events of Deep vein thrombosis and cerebrovascular accident. The events occurred 3 days after the second dose of mRNA-1273 Moderna vaccine. The rechallenge was not applicable, as the outcome of the events was unknown.  The medical history of Type 2 diabetes mellitus and Hypertension could be confounders.  The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.